ES2118674T3 - Nuevos inhibidores selectivos de neuraminidasas virales o bactericidas. - Google Patents

Nuevos inhibidores selectivos de neuraminidasas virales o bactericidas.

Info

Publication number
ES2118674T3
ES2118674T3 ES96912404T ES96912404T ES2118674T3 ES 2118674 T3 ES2118674 T3 ES 2118674T3 ES 96912404 T ES96912404 T ES 96912404T ES 96912404 T ES96912404 T ES 96912404T ES 2118674 T3 ES2118674 T3 ES 2118674T3
Authority
ES
Spain
Prior art keywords
group
bactericides
selective inhibitors
new selective
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96912404T
Other languages
English (en)
Spanish (es)
Other versions
ES2118674T1 (es
Inventor
Norbert W Bischofberger
Choung U Kim
Willard Lew
Hongtao Liu
Matthew A Williams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gilead Sciences Inc
Original Assignee
Gilead Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27410155&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2118674(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/476,946 external-priority patent/US5866601A/en
Application filed by Gilead Sciences Inc filed Critical Gilead Sciences Inc
Publication of ES2118674T1 publication Critical patent/ES2118674T1/es
Application granted granted Critical
Publication of ES2118674T3 publication Critical patent/ES2118674T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Polyesters Or Polycarbonates (AREA)
ES96912404T 1995-02-27 1996-02-26 Nuevos inhibidores selectivos de neuraminidasas virales o bactericidas. Expired - Lifetime ES2118674T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39524595A 1995-02-27 1995-02-27
US08/476,946 US5866601A (en) 1995-02-27 1995-06-06 Carbocyclic compounds
US58056795A 1995-12-29 1995-12-29

Publications (2)

Publication Number Publication Date
ES2118674T1 ES2118674T1 (es) 1998-10-01
ES2118674T3 true ES2118674T3 (es) 2000-08-16

Family

ID=27410155

Family Applications (2)

Application Number Title Priority Date Filing Date
ES96912404T Expired - Lifetime ES2118674T3 (es) 1995-02-27 1996-02-26 Nuevos inhibidores selectivos de neuraminidasas virales o bactericidas.
ES99117934T Expired - Lifetime ES2249863T3 (es) 1995-02-27 1996-02-26 Inhibidores selectivos de neuraminidasa viral o bacteriana.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES99117934T Expired - Lifetime ES2249863T3 (es) 1995-02-27 1996-02-26 Inhibidores selectivos de neuraminidasa viral o bacteriana.

Country Status (26)

Country Link
US (3) US5952375A (enExample)
EP (1) EP0759917B1 (enExample)
JP (3) JP3300365B2 (enExample)
KR (1) KR100447096B1 (enExample)
CN (2) CN100409844C (enExample)
AT (2) ATE305453T1 (enExample)
AU (1) AU720933B2 (enExample)
BR (2) BR9607098B8 (enExample)
CZ (1) CZ297945B6 (enExample)
DE (4) DE759917T1 (enExample)
DK (1) DK0759917T3 (enExample)
ES (2) ES2118674T3 (enExample)
GR (1) GR3033914T3 (enExample)
HU (1) HU228450B1 (enExample)
LU (1) LU90991I2 (enExample)
MX (1) MX9706496A (enExample)
NL (1) NL300105I2 (enExample)
NO (1) NO318455B1 (enExample)
NZ (1) NZ306625A (enExample)
PL (1) PL194173B1 (enExample)
PT (1) PT759917E (enExample)
RU (1) RU2181357C2 (enExample)
SG (1) SG45864A1 (enExample)
SI (1) SI9620042A (enExample)
UA (1) UA56128C2 (enExample)
WO (1) WO1996026933A1 (enExample)

Families Citing this family (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI9620042A (sl) * 1995-02-27 1998-12-31 Gilead Sciences, Inc. Novi selektivni inhibitorji virusnih ali bakterijskih neuraminidaz
US5714509A (en) * 1995-05-03 1998-02-03 The University Of Alabama Inhibitors of bacterial sialidase and methods of making and using the same
US5763483A (en) * 1995-12-29 1998-06-09 Gilead Sciences, Inc. Carbocyclic compounds
US6093816A (en) 1996-06-27 2000-07-25 Isis Pharmaceuticals, Inc. Cationic lipids
US5859284A (en) * 1996-08-23 1999-01-12 Gilead Sciences, Inc. Preparation of carbocyclic compounds
US6518438B2 (en) 1996-08-23 2003-02-11 Gilead Sciences, Inc. Preparation of cyclohexene carboxylate derivatives
JP3622983B2 (ja) * 1996-08-23 2005-02-23 ギリアード サイエンシーズ， インコーポレイテッド シクロヘキセンカルボキシレート誘導体の調製
KR20000052702A (ko) * 1996-10-21 2000-08-25 헨슬레이 맥스 디. 피페리딘 화합물
US5994377A (en) 1996-10-21 1999-11-30 Gilead Sciences, Inc. Piperidine compounds
TR199901081T2 (xx) * 1996-11-14 1999-08-23 Biota Scientific Management Pty.Ltd. Y�ntem ve bu y�ntemde kullan�lan yeni bile�imler.
US6020344A (en) * 1997-08-01 2000-02-01 University Of Florida Enzyme inhibitors and methods of use
US5886213A (en) * 1997-08-22 1999-03-23 Gilead Sciences, Inc. Preparation of carbocyclic compounds
US20040053999A1 (en) * 1997-09-17 2004-03-18 Bischofberger Norbert W. Novel compounds and methods for synthesis and therapy
JP2001516739A (ja) * 1997-09-17 2001-10-02 ギリアード サイエンシーズ， インコーポレイテッド ６員環を含む化合物、それらの調製プロセス、および医薬としてのそれらの使用
TW480247B (en) * 1997-12-12 2002-03-21 Gilead Sciences Inc Novel compounds useful as neuraminidase inhibitors and pharmaceutical compositions containing same
AU2200199A (en) * 1997-12-17 1999-07-19 Biocryst Pharmaceuticals, Inc. Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors
US6518305B1 (en) 1998-04-23 2003-02-11 Abbott Laboratories Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases
HUP0101224A3 (en) * 1998-04-23 2002-12-28 Abbott Lab Pyrrolidine derivatives as inhibitors of neuraminidases and pharmaceutical compositions containing them
US6455571B1 (en) 1998-04-23 2002-09-24 Abbott Laboratories Inhibitors of neuraminidases
DK0957078T3 (da) * 1998-05-13 2002-04-02 Hoffmann La Roche Fremgangsmåde til fremstilling af shikimisyre og derivater deraf
AU1476900A (en) * 1998-11-13 2000-06-05 Gilead Sciences, Inc. 1,4,5,6-tetrahydro-pyridazine derivatives, their preparation and their use as neuraminidase inhibitors
AUPP913999A0 (en) * 1999-03-12 1999-04-01 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
EP1059283B1 (en) 1999-06-11 2003-05-28 F. Hoffmann-La Roche Ag Process for preparing neuraminidase inhibitor ro-64-0796
DE19930177B4 (de) 1999-06-30 2007-02-08 Nikolai Vladimirovich Bovin Intermolekular assoziierende Verbindungen und deren Verwendung
US6593314B1 (en) 1999-10-19 2003-07-15 Abbott Laboratories Neuraminidase inhibitors
BR0010525A (pt) * 1999-10-19 2002-11-26 Abbott Lab cido 1-ciclo-hexeno-1-carboxìlico e 1-ciclo-hexeno-1carboxilatos como inibidores de neuraminidase
US6627396B1 (en) * 1999-10-28 2003-09-30 The Regents Of The University Of California Influenza sensor
JP2001131144A (ja) 1999-11-02 2001-05-15 Sagami Chem Res Center ７−アザビシクロ［４．１．０］ヘプト−３−エン−３−カルボン酸エステル類の製造方法
US6462226B1 (en) 1999-12-03 2002-10-08 Hoffmann-La Roche Inc. Process for the preparation of 4,5-diamino shikimic acid derivatives
WO2001047906A1 (en) * 1999-12-27 2001-07-05 Sagami Chemical Research Center Process for the production of 5-oxy-7-oxabicyclo-[4.1.0]hept-3-e ne-3-carboxylic acid esters
US8642051B2 (en) * 2000-03-21 2014-02-04 Suzanne Jaffe Stillman Method of hydration; infusion packet system(s), support member(s), delivery system(s), and method(s); with business model(s) and Method(s)
AU2001252578A1 (en) * 2000-04-25 2001-11-07 Sankyo Company Limited Preventives for influenza
GB0015324D0 (en) * 2000-06-22 2000-08-16 Biota Scient Management Medicaments
MXPA02012583A (es) 2000-06-27 2003-04-10 Hoffmann La Roche Metodo para preparacion de una composicion.
AUPR001000A0 (en) 2000-09-08 2000-10-05 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
WO2002092555A1 (en) * 2001-05-11 2002-11-21 Sankyo Company, Limited Sialic acid derivatives
US6964784B2 (en) * 2002-03-07 2005-11-15 Optigenex, Inc. Method of preparation and composition of a water soluble extract of the bioactive component of the plant species uncaria for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals
RU2220739C1 (ru) * 2002-08-30 2004-01-10 Гапонюк Петр Яковлевич Интраназальное средство
US7807174B2 (en) * 2002-11-22 2010-10-05 Nexbio, Inc. Class of therapeutic protein based molecules
US7122684B2 (en) 2003-03-13 2006-10-17 Roche Colorado Corporation Process for preparing 1,2-diamino compounds
ATE496056T1 (de) 2003-06-16 2011-02-15 Acad Of Science Czech Republic Pyrimidinverbindungen mit phosphonatgruppen als antivirale nucleotidanaloga
WO2007053792A2 (en) * 2005-11-05 2007-05-10 Amplyx Pharmaceuticals, Inc. Improving the pharmacokinetics of protease inhibitors and other drugs
WO2007060681A1 (en) * 2005-11-25 2007-05-31 Hetero Drugs Limited Improved process for oseltamivir phosphate
KR100819759B1 (ko) 2005-12-01 2008-04-07 (주)파인켐 아자이드 화합물의 폭발성을 제거한 공정을 이용한 1,2-다이아미노 화합물 또는 이의 부가염 제조 방법
KR20080085061A (ko) 2005-12-28 2008-09-22 에프. 호프만-라 로슈 아게 타미플루 합성에서의 에폭사이드 중간체
WO2007097325A1 (ja) * 2006-02-20 2007-08-30 Chugai Seiyaku Kabushiki Kaisha リン酸オセルタミビル含有医薬組成物
US20080063722A1 (en) * 2006-09-08 2008-03-13 Advanced Inhalation Research, Inc. Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI)
US20080306098A1 (en) * 2006-11-06 2008-12-11 Mutz Mitchell W Pharmacokinetics of protease inhibitors and other drugs
US8227425B2 (en) 2007-01-23 2012-07-24 Therapicon Srl Antiviral compounds
US20080194801A1 (en) * 2007-02-14 2008-08-14 Swanson Basil I Robust multidentate ligands for diagnosis and anti-viral drugs for influenza and related viruses
US8435769B2 (en) 2007-04-13 2013-05-07 Monsanto Technology Llc Use of glyphosate to produce shikimic acid in microorganisms
US20090054334A1 (en) * 2007-05-23 2009-02-26 Mutz Mitchell W Combinatorial improvement of bifunctional drug properties
CN101883569B (zh) * 2007-08-31 2013-08-21 梁启铭 具有抗流感活性之含奥司他伟膦酸酯同系物的合成
EP2201123B1 (en) 2007-10-16 2012-01-18 Monsanto Technology, LLC Processes for recovering shikimic acid
WO2009055042A1 (en) * 2007-10-24 2009-04-30 Amplyx Pharmaceuticals, Inc. Enhancing the efficacy of anti-infective therapeutics
WO2009078813A1 (en) * 2007-12-19 2009-06-25 Nanyang Technological University Method of forming oseltamivir and derivatives thereof
US8334319B2 (en) * 2008-01-04 2012-12-18 Roche Palo Alto Llc Polymorphic forms of oseltamivir phosphate
US20100081713A1 (en) * 2008-03-19 2010-04-01 CombinatoRx, (Singapore) Pte. Ltd. Compositions and methods for treating viral infections
EP2276479B1 (en) 2008-04-15 2014-07-02 SineVir Therapeutics LLC Prodrugs of neuraminidase inhibitors
TWI491416B (zh) 2008-12-24 2015-07-11 Daiichi Sankyo Co Ltd 吸入用乾燥粉末醫藥組成物
CN101486664B (zh) * 2008-12-31 2013-09-04 北京大学深圳研究生院 用作流感病毒神经氨酸酶抑制剂的多取代五元环小分子化合物
EA201101564A1 (ru) 2009-05-15 2012-07-30 Редкс Фарма Лимитед Редокс производные лекарственных средств
WO2011021223A2 (en) * 2009-08-19 2011-02-24 Msn Laboratories Limited Novel salts of ethyl (3r, 4s, 5r)-4,5-imino-3-(l-ethylpropoxy)-1- cvclohexene-1-carboxylate and its use
WO2011059994A2 (en) * 2009-11-11 2011-05-19 3M Innovative Properties Company Polymeric compositions and method of making and articles thereof
IT1396620B1 (it) 2009-11-25 2012-12-14 Therapicon Srl Analoghi chimerici
EA201300142A1 (ru) 2010-07-16 2013-08-30 Гриндекс, Джоинт Сток Кампани Производные 1,4-дигидропиридина, обладающие противовирусной эффективностью
AT510585B1 (de) 2010-11-18 2012-05-15 Apeptico Forschung & Entwicklung Gmbh Zusammensetzung umfassend ein peptid und ein hemmstoff der viralen neuraminidase
KR101369584B1 (ko) 2011-04-19 2014-03-06 일양약품주식회사 페닐-이속사졸 유도체 및 그의 제조방법
EP2578218A1 (en) 2011-10-06 2013-04-10 Grindeks, A Joint Stock Company Antiviral efficacy of disodium 2,6-dimethyl-1,4-dihydropyridine-3,5-bis(carbonyloxyacetate) and its derivatives
DE102011117128A1 (de) 2011-10-28 2013-05-02 Christian-Albrechts-Universität Zu Kiel Verbindungen zur Therapie der Influenza
RU2469020C1 (ru) * 2011-11-08 2012-12-10 Александр Васильевич Иващенко (3r,4r,5s)-5-амино-4-ациламино-3-(1-этил-пропокси)-циклогекс-1-ен-карбоновые кислоты, их эфиры и способ применения
RU2489422C1 (ru) * 2012-05-12 2013-08-10 Александр Васильевич Иващенко Фторзамещенные (3r,4r,5s)-5-гуанидино-4-ациламино-3-(пентан-3-илокси)циклогексен-1-карбоновые кислоты, их эфиры и способ применения
RU2521593C1 (ru) * 2013-02-27 2014-06-27 Общество с ограниченной ответственностью "Интеллектуальный Диалог" Моно и дифторзамещенные этил (3r,4r,5s)-5-азидо-4-ацетиламино-3-(1-этилпропокси)-циклогексен-1-карбоксилаты, способ получения и применения
JP6453050B2 (ja) * 2013-11-15 2019-01-16 国立大学法人富山大学 ２−デオキシ−２，３−ジデヒドロシアル酸誘導体およびその製造法
CN103819357B (zh) * 2014-01-28 2016-03-16 浙江大学 (-)-有效霉醇叠氮四乙酸酯的制备方法
US9950989B2 (en) 2014-02-14 2018-04-24 Toa Eiyo Ltd. Cyclic hydrocarbon compound
CN107072976A (zh) 2014-05-12 2017-08-18 葛兰素史克知识产权第二有限公司 用于治疗传染性疾病的包含Danirixin的药物组合物
US9392814B2 (en) 2014-06-06 2016-07-19 Nicholas J. Singer Delivery system for drinks
GB2532178A (en) * 2014-06-09 2016-05-18 Redx Pharma Plc Antiviral compounds
CN118286245A (zh) 2014-12-26 2024-07-05 埃莫里大学 N4-羟基胞苷和衍生物及与其相关的抗病毒用途
USD773313S1 (en) 2015-06-23 2016-12-06 Nicholas J. Singer Package
US10676428B2 (en) 2015-12-17 2020-06-09 Ramot At Tel-Aviv University Ltd. Antiviral agents for amantadine-resistant influenza A
KR102339817B1 (ko) 2016-06-30 2021-12-16 한미약품 주식회사 오셀타미비어 함유 경구용 고형제제 및 그 제조방법
CR20190123A (es) * 2016-08-10 2019-04-30 Shionogi & Co Composiciones farmacéuticas que contienen derivados de piridona policíclicos sustituídos y profármacos de los mismos
US11331331B2 (en) 2017-12-07 2022-05-17 Emory University N4-hydroxycytidine and derivatives and anti-viral uses related thereto
KR20200106607A (ko) 2019-03-05 2020-09-15 주식회사 코아팜바이오 오셀타미비르 함유 의약 조성물

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4968788A (en) * 1986-04-04 1990-11-06 Board Of Regents, The University Of Texas System Biologically reversible phosphate and phosphonate protective gruops
US5206400A (en) * 1986-07-07 1993-04-27 Ohio State University Diastereomeric mono- and di-substituted diamino cyclohexane compounds and the method of preparation thereof
AU2947889A (en) * 1988-01-12 1989-08-11 Board Of Regents, The University Of Texas System Histamine release inhibitory factor and preparations therefore
US5175273A (en) * 1988-07-01 1992-12-29 Genentech, Inc. Nucleic acid intercalating agents
US5270340A (en) * 1988-12-27 1993-12-14 Bayer Aktiengesellschaft Substituted 2-cyclohexen-1-yl-amine fungicidal and herbicidal agents
GB2238049A (en) * 1989-11-22 1991-05-22 Ki Nii Epidemiologii I Infekts Method for preparing inhibitor for influenza virus neuraminidase
AP249A (en) * 1990-04-24 1993-03-17 Biota Scient Management Pty Ltd Anti-viral compounds.
WO1992006691A1 (en) * 1990-10-19 1992-04-30 Biota Scientific Management Pty. Ltd. Anti-viral compounds that bind the active site of influenza neuramidase and display in vivo activity against orthomyxovirus and paramyxovirus
DE4033415A1 (de) * 1990-10-20 1992-04-23 Bayer Ag Antimikrobielle mittel sowie substituierte 2-cyclohexan-1-yl-amin-derivate und deren herstellung
DE4131311A1 (de) * 1991-09-20 1993-04-01 Basf Ag Dihydropyranderivate und diese enthaltende pflanzenschutzmittel
AU659501B2 (en) * 1991-10-23 1995-05-18 Biota Scientific Management Pty Ltd Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of alpha-D-neuraminic acid
GB9126725D0 (en) * 1991-12-17 1992-02-12 Glaxo Group Ltd Process
FR2687674B1 (fr) * 1992-02-07 1995-05-19 Roussel Uclaf Nouveaux derives de la pyridone, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
US5292938A (en) * 1992-04-13 1994-03-08 Associated Universities, Inc. Synthesis of 4-substituted-trans-1, 2-diaminocyclohexyl polyaminocarboxylate metal chelating agents for the preparation of stable radiometal antibody immunoconjugates for therapy and spect and pet imaging
US5633360A (en) 1992-04-14 1997-05-27 Gilead Sciences, Inc. Oligonucleotide analogs capable of passive cell membrane permeation
GB9220327D0 (en) * 1992-09-25 1992-11-11 Glaxo Group Ltd Process
GB9220241D0 (en) * 1992-09-25 1992-11-11 Glaxo Group Ltd Process
US5639786A (en) * 1992-12-04 1997-06-17 Biota Scientific Management, Pty., Ltd. Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of α-D-neuraninic acid
US5514798A (en) * 1993-06-02 1996-05-07 Gilead Sciences, Inc. Method and cyclic carbonates for nucleotide analogues
US5819730A (en) * 1993-06-09 1998-10-13 Glaxo Wellcome Australia Ltd. Device for administering pharmaceutical substances
GB9311873D0 (en) * 1993-06-09 1993-07-28 Glaxo Group Ltd Process
GB9312531D0 (en) * 1993-06-17 1993-08-04 Glaxo Group Ltd Process
GB9325841D0 (en) * 1993-12-17 1994-02-23 Glaxo Group Ltd Chemical compounds
GB9400206D0 (en) * 1994-01-07 1994-03-02 Glaxo Group Ltd Chemical compound
AUPM354694A0 (en) * 1994-01-27 1994-02-17 Biota Scientific Management Pty Ltd Chemical compounds
US5985859A (en) * 1994-04-14 1999-11-16 The University Of Alabama Methods of inhibiting bacterial sialidase
GB9410817D0 (en) * 1994-05-28 1994-07-20 Glaxo Group Ltd Medicaments
AUPM725794A0 (en) * 1994-08-03 1994-08-25 Biota Scientific Management Pty Ltd Chemical compounds
US5556963A (en) * 1994-08-05 1996-09-17 Oklahoma Medical Research Foundation Synthesis of 4-alkoxy-N-acetylneuraminic acid
GB9416365D0 (en) * 1994-08-12 1994-10-05 Glaxo Group Ltd Medicaments
US5512596A (en) * 1994-09-02 1996-04-30 Gilead Sciences, Inc. Aromatic compounds
WO1996014314A2 (en) 1994-11-04 1996-05-17 Gilead Sciences, Inc. Thiepane compounds inhibiting and detecting hiv protease
US5866601A (en) * 1995-02-27 1999-02-02 Gilead Sciences, Inc. Carbocyclic compounds
SI9620042A (sl) * 1995-02-27 1998-12-31 Gilead Sciences, Inc. Novi selektivni inhibitorji virusnih ali bakterijskih neuraminidaz
US5602277A (en) 1995-03-30 1997-02-11 Biocryst Pharmaceuticals, Inc. Substituted benzene derivatives useful as neuraminidase inhibitors
US5714509A (en) 1995-05-03 1998-02-03 The University Of Alabama Inhibitors of bacterial sialidase and methods of making and using the same
GB9525389D0 (en) 1995-12-12 1996-02-14 Biota Scient Management Ltd Chemical compounds
GB9510141D0 (en) 1995-05-19 1995-07-12 Biota Scient Management Chemical compounds
JP4162712B2 (ja) * 1995-05-19 2008-10-08 バイオタ、サイアンティフィック、マネージメント、プロプライエタリ、リミテッド ６−カルボキサミドジヒドロピラン誘導体
GB9516276D0 (en) * 1995-08-08 1995-10-11 Biota Scient Management Chemical compounds
US5763483A (en) * 1995-12-29 1998-06-09 Gilead Sciences, Inc. Carbocyclic compounds
JP3622983B2 (ja) 1996-08-23 2005-02-23 ギリアード サイエンシーズ， インコーポレイテッド シクロヘキセンカルボキシレート誘導体の調製
US5859284A (en) 1996-08-23 1999-01-12 Gilead Sciences, Inc. Preparation of carbocyclic compounds
AU711845B2 (en) * 1996-09-10 1999-10-21 Daikin Industries, Ltd. 4-substituted-2,7-dideoxy-7-fluoro-2,3-didehydro-sialic acid compounds
US5886213A (en) 1997-08-22 1999-03-23 Gilead Sciences, Inc. Preparation of carbocyclic compounds

Also Published As

Publication number Publication date
SG45864A1 (en) 1999-04-27
CN1185223C (zh) 2005-01-19
PT759917E (pt) 2000-10-31
US6225341B1 (en) 2001-05-01
SI9620042A (sl) 1998-12-31
DE69607704D1 (de) 2000-05-18
JPH11501908A (ja) 1999-02-16
NO318455B1 (no) 2005-03-21
UA56128C2 (uk) 2003-05-15
NO973908D0 (no) 1997-08-26
US5952375A (en) 1999-09-14
BR9607098A (pt) 1997-11-04
BR9607098B8 (pt) 2014-11-18
HUP9800026A2 (hu) 1999-09-28
KR19980703600A (ko) 1998-12-05
EP0759917B1 (en) 2000-04-12
HUP9800026A3 (en) 2002-04-29
JP3300365B2 (ja) 2002-07-08
CZ297945B6 (cs) 2007-05-02
ES2118674T1 (es) 1998-10-01
DE69635231D1 (de) 2006-02-09
GR3033914T3 (en) 2000-11-30
CN1147813A (zh) 1997-04-16
DE69635231T2 (de) 2006-07-13
PL194173B1 (pl) 2007-05-31
HU228450B1 (en) 2013-03-28
DK0759917T3 (da) 2000-07-31
AU5357196A (en) 1996-09-18
HK1026893A1 (en) 2000-12-29
JP2006036770A (ja) 2006-02-09
CZ269097A3 (en) 1997-11-12
CN1347693A (zh) 2002-05-08
NL300105I1 (nl) 2003-01-06
ES2249863T3 (es) 2006-04-01
ATE305453T1 (de) 2005-10-15
DE69607704T2 (de) 2000-12-28
DE10299052I1 (de) 2003-05-22
RU2181357C2 (ru) 2002-04-20
AU720933B2 (en) 2000-06-15
MX9706496A (es) 1997-11-29
PL322000A1 (en) 1998-01-05
NZ306625A (en) 2001-04-27
LU90991I2 (fr) 2003-02-11
ATE191711T1 (de) 2000-04-15
NL300105I2 (nl) 2003-02-03
EP0759917A1 (en) 1997-03-05
JP4234917B2 (ja) 2009-03-04
DE759917T1 (de) 1998-10-22
NO973908L (no) 1997-10-27
CN100409844C (zh) 2008-08-13
KR100447096B1 (ko) 2005-10-11
WO1996026933A1 (en) 1996-09-06
US20050176758A1 (en) 2005-08-11
JP2002161074A (ja) 2002-06-04

Similar Documents

Publication Publication Date Title
ES2118674T3 (es) Nuevos inhibidores selectivos de neuraminidasas virales o bactericidas.
AR013960A1 (es) Nuevos compuestos y metodos para sintesis y terapia
NO984004D0 (no) FremgangsmÕte for pÕvisning av influensavirus og forbindelser for anvendelse ved fremgangsmÕten
UY24555A1 (es) Nuevos compuestos
ATE278803T1 (de) Verfahren zur überwachung der proteasomeinhibitorarzneimitteleffekte
AP9901531A0 (en) Method and novel compounds for use therein.
PT99267A (pt) Processo para a preparacao de novos derivados de mercaptoacetilamida e de composicoes farmaceuticas que os contem
ES554453A0 (es) Un metodo para detectar la presencia de virus lav-htlv-iii o de anticuerpo para virus lav-htlv-iii
EP0755372A4 (en) INHIBITORS OF THE NEURAMINIDASE OF THE FLU VIRUS AND METHOD FOR THE PRODUCTION AND USE THEREOF
BR9812783A (pt) "sistemas de detecção para o registro de interações e as relações funcionais de proteìnas"
EA199900552A1 (ru) Асимметрический способ получения бензоксазинонов
FI960149L (fi) Kumariinien ja karbostyriilien käyttö PLA2:n estäjinä, uusia kumariineja ja karbostyriilejä, menetelmä niiden valmistamiseksi ja lääkkeitä
EA200200435A1 (ru) Анализ лептина
CY1110429T1 (el) Προσδιορισμος
EP0976734A3 (en) Selective inhibitors of viral or bacterial neuraminidase
AR004719A1 (es) Compuestos debisindolilmaleimidas con un punte n, n' y formulaciones farmaceuticas que los contienen, dichos compuestos son utiles comointermediarios para preparar otras bisindolilmaleimidas que poseen dicho puente n, n'
PT989994E (pt) Derivados de estreptograminas, a sua preparacao e as composicoes que os contem
BR9809078A (pt) Peptìdeos sintéticos utilizáveis nos testes biológicos para a detecção das infecções devido aos vìrus hiv1 do grupo o
BR9712910A (pt) ra o tratamento de infecção por hiv
ATE317454T1 (de) Verfahren zur aktivitätsbestimmung einer substanz mittels eines funktionellen in vitro tests
EA199901049A2 (ru) Спироимидазолиновые соединения, способ их получения и фармацевтическая композиция, содержащая их
AR014093A1 (es) Una molecula de acido nucleico aislado, una proteina aislada de pulga, una composicion terapeutica, su uso, metodo para producir laproteina, metodo in vitro para identificar un compuesto capaz de inhibir la actividad de la proteasa de la pulga y la actividad de
FI944967A0 (fi) Menetelmiä proteolyyttisen entsyymin inhibiittoreina käyttökelpoisten sakkariinijohdannaisten ja niiden välituotteiden valmistamiseksi
BR9704825A (pt) Sistema de apresentação de relatórios de exames vasculares obtidos através de ultra-som
ECSP972067A (es) Compuestos heterociclicos

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 759917

Country of ref document: ES

SPCF Request for supplementary protection certificate filed

Free format text: OSELTAMIVIR (TAMIFLU)

Spc suppl protection certif: C200200036

Filing date: 20021220

SPCG Supplementary protection certificate granted

Free format text: OSELTAMIVIR (TAMIFLU)

Spc suppl protection certif: C200200036

Filing date: 20021220

Expiry date: 20170620

Effective date: 20040309